Skip to main content
PLOS One logoLink to PLOS One
. 2023 Dec 7;18(12):e0295291. doi: 10.1371/journal.pone.0295291

Transcriptome and metabolomics analysis of adaptive mechanism of Chinese mitten crab (Eriocheir sinensis) to aflatoxin B1

Hongsheng Yang 1,2,, Meifang Shen 1, Qiuyun Zhang 2, Yifeng Li 3, Xiuhui Tan 2, Xuguang Li 2, Huimin Chen 4, Lei Wu 5, Shaofang He 5, Xiaohua Zhu 1,*
Editor: Amel Mohamed El Asely6
PMCID: PMC10703319  PMID: 38060597

Abstract

Aflatoxin B1 (AFB1), with the strong toxicity and carcinogenicity, has been reported to great toxicity to the liver and other organs of animals. It cause huge economic losses to breeding industry, including the aquaculture industry. Chinese mitten crabs (Eriocheir sinensis), as one of important species of freshwater aquaculture in China, are deeply disturbed by it. However, the molecular and metabolic mechanisms of hepatopancreas and ovary in crabs underlying coping ability are still unclear. Hence, we conducted targeted injection experiment with or without AFB1, and comprehensively analyzed transcriptome and metabolomics of hepatopancreas and ovary. As a result, 210 and 250 DEGs were identified in the L-C vs. L-30 m and L-C vs. L-60 m comparison, among which 14 common DEGs were related to six major functional categories, including antibacterial and detoxification, ATP energy reaction, redox reaction, nerve reaction, liver injury repair and immune reaction. A total of 228 and 401 DAMs in the ML-C vs. ML-30 m and ML-C vs. ML-60 m comparison both enriched 12 pathways, with clear functions of cutin, suberine and wax biosynthesis, tyrosine metabolism, purine metabolism, nucleotide metabolism, glycine, serine and threonine metabolism, ABC transporters and tryptophan metabolism. Integrated analysis of metabolomics and transcriptome in hepatopancreas discovered three Co-enriched pathways, including steroid biosynthesis, glycine, serine and threonine metabolism, and sphingolipid metabolism. In summary, the expression levels and functions of related genes and metabolites reveal the regulatory mechanism of Chinese mitten crab (Eriocheir sinensis) adaptability to the Aflatoxin B1, and the findings contribute to a new perspective for understanding Aflatoxin B1 and provide some ideas for dealing with it.

Introduction

Aflatoxin is a secondary metabolite produced by Aspergillus flavus and Aspergillus parasiticus, and is a highly toxic natural pollutant widely present in feed in humid and hot areas [1, 2]. Among the 12 aflatoxin derivatives detected, the most toxic and carcinogenic aflatoxin B1 (AFB1) is the most common, with significant toxicity to the liver and other organs of animals [3].

In recent years, aflatoxin pollution has caused huge economic losses to breeding industry, including aquaculture industry [4]. According to data from the Food and Agriculture Organization (FAO) of the United Nations, approximately 25% of crops worldwide are contaminated with varying degrees of aflatoxin every year, and about 2% of crops lose their feed value due to severe pollution [5, 6].

The effects of AFB1 on aquatic animals have been widely reported in many research articles both domestically and internationally, such as Oreochromis niloticus [7, 8], Oncorhynchus mykiss [9], Litopenaeus vannamei [10], Lctalurus punctatus [11], Labeo rohita [12] and other species. According to reports, due to feeding Oreochromis niloticus with AFB1 for 10 weeks, the growth rate slows down and the mortality rate gradually increases [13]. The reproductive capacity of Carassius auratus gibelio fed with AFB1 is severely affected [14]. Current research shows that AFB1 can cause abnormal behavior, slow growth, immunosuppression, antioxidant damage and tissue lesions of aquatic animals [1517]. If AFB1 accumulates in the body tissues of aquatic animals and spreads further in the ecosystem along with the food chain, it may threaten human health [18]. Therefore, the agricultural industry standard of the People’s Republic of China (NY5072-2002) stipulates that the safety limit of AFB1 in fishery composite feed is 10μg/kg [19].

Chinese mitten crab (Eriocheir sinensis) is one of the important species in freshwater aquaculture in China, which has produced good economic benefits [20]. In recent years, with the continuous expansion of aquaculture scale and the continuous improvement of intensification, various diseases have emerged in Chinese mitten crab, seriously hampering its healthy development [21]. As mentioned above, we are aware that AFB1 has significant toxicity to animal livers [3]. We analyzed the obtained data in this experiments and explained some molecular response mechanism in the results. The 400 μl aflatoxin B1 of standard solution was injected into the tested crabs, and the experimental data of hepatopancreas and ovary within one hour after treatment were obtained through transcriptome sequencing and metabonomics methods. The results of this experiment provide data support for our study on the stress response of aflatoxin B1 to crabs, and provide ideas for solving the practical production problems of aflatoxin B1 on crabs in the future.

Materials and methods

Experimental reagent

The aflatoxin B1 standard, with a purity of 99.8%, was provided by Israel FERMENTEK Company. The Dimethyl sulfoxide (chromatographically pure) was provided by ROE Company of the United States. The standard AFB1 working solution, with a concentration of 60 mg/L, was prepared by weighing 6 mg of aflatoxin B1 standard and dissolving it with 100 ml of dimethyl sulfoxide. The blank working solution was prepared using a single dimethyl sulfoxide reagent.

Experimental design and sample collection

More than 18 female experimental crabs were raised at the Pukou Breeding Base in Nanjing, Jiangsu Province, China. Before the experiment, 18 female crabs with an initial average weight of (125±12g) were randomly divided into three groups. Two groups of female experimental crabs were injected with disposable needles for 400 μl AFB1 standard solution with a concentration of 60 mg/L, and the third group was injected with 400 μl blank working solution. The hepatopancreas and ovaries of experimental crabs injected with AFB1 in first group were taken out after 30 minutes, and those in the second group were taken out after 60 minutes. The hepatopancreas and ovaries of experimental crabs injected with blank working solution were taken out as control after 30 minutes. The samples were frozen with liquid nitrogen and quickly stored in an ultra-low temperature refrigerator (-80°C). Six samples in each group were used for metabolomics, and three samples in each group were randomly selected for transcriptome sequencing.

RNA extraction and transcriptome sequencing

Total RNA was extracted from frozen samples using Trizol reagent method (DP762-T1C). RNA purity and integrity were assessed by a NanoPhotometer® spectrophotometer (IMPLEN, CA, USA) and a RNA Nano 6000 Assay Kit on the Agilent Bioanalyzer 2100 system (Agilent Technologies, CA, USA). RNA contamination and degradation were assessed by 1.5% agarose gel electrophoresis.

A total of 1 μg of RNA per sample was used as the input material for library preparation. The mRNA was purified from the total RNA using poly-T oligo-attached magnetic beads. Sequencing libraries from the above three groups (one control and two treatments) were constructed with the purified mRNA using the NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, USA). According to the manufacturer’s recommendations, The cDNA library preparations for next-generation sequencing were generated from each sample. Each cDNA library was purified with AMPure XP system (Beckman Coulter, Beverly, MA, USA) and its quality was assessed by using Agilent RNA 6000 Nano Kit on the Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). The index codes were added to attribute sequences to each sample, and the cDNA libraries constructed by the above reaction system were performed on an Illumina HiSeq X Ten platform by Frasergen Bioinformatics Co., Ltd. (Wuhan, China). As a result, 150-bp paired-end reads were generated and then entered the filtering quality control process.

The clean reads were aligned to the reference genome Chinese mitten crab (Eriocheir sinensis) (https://www.ncbi.nlm.nih.gov/assembly/GCF_024679095.1) using HISAT 2 software [22]. Use Samtools to compress and sort mapping files, and use String Tie software for read assembly and abundance estimation [23]. In this experiment, the fragments per kilobase of exon per million fragments mapped reads (FPKM) represented the relative expression of genes, and FDR was a prerequisite for determining whether it was a differentially expressed gene (DEG). The list of DESeq2 identified DEGs, and the screening criteria for DEGs was FDR < 0.05 and fold change ≥ 2. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment was performed using phyper R package.

Metabolic profiling

100 mg powdered samples were homogenized and were extracted with 1.0 mL pre-chilled 80% methanol solution containing 0.1% (v/v) formic acid at 4°C overnight. The extracts were centrifuged for 10 min at 4°C, 10,000 g, then absorbed and diluted into a concentration containing 53% methanol. The supernatant was filtrated before LC-ESI-MS/MS system (HPLC, Shim-pack UFLC SHIMADZU CBM30A system; MS, Applied Biosystems 4500 Q TRAP). LC–MS/MS analyses were performed using an ExionLCTM AD system coupled with a QTRAP® 6500+ mass spectrometer (both from SCIEX, Framingham, MA, USA). It described the system including the high performance liquid chromatography (HPLC) and MS conditions by He et al [24].

Identification and quantification of metabolites were analyzed using the MultiaQuant and Analyst software (1.6.1). The multivariate analysis of metabolites, including model evaluation, was conducted by the orthogonal partial least squares discriminant analysis (OPLS-DA) with score plots and permutation plots. The differential metabolites were screened by combining the differential multiple, P value of the t-test and VIP value of the OPLS-DA model, and the screening standard was FC > 1, P value < 0.05 and VIP > 1. The identified metabolites were aligned to GO and KEGG database, and the significantly enriched functions explained the differences between sample groups.

Results

Transcriptome (RNA-seq) analysis

Data acquisition of transcriptome

In this study, transcriptome data of hepatopancreas (L) and ovary (R) were statistically analyzed. A total of 18 experimental samples generated over 148.12 Gb of clean data. The clean data from each sample reached at least 6.08 Gb and the percentage of Q30 bases was 93.90% and above (Table 1). Mapping ratio between clean reads and the reference genome of Eriocheir sinensis (https://www.ncbi.nlm.nih.gov/assembly/GCF_024679095.1) ranged from 80.27 to 88.34%, with an average of 84.86% (Table 1). Principal component analysis (PCA) showed significant differences between the the untreated group (C) and the treat groups (30 m, 60 m) in hepatopancreas and ovary, respectively. The changes after treatment were not uniform, and the repeatability within each group was acceptable. PC1(40.44%) and PC2 (25.09%) effectively separated the control samples from the treatment samples in hepatopancreas (Fig 1A), and PC1(39.64%) and PC2 (24.14%) separated the control samples from the treatment samples in ovary (Fig 1A). The above results demonstrated that the processing method and the data obtained could be used.

Table 1. Data statistics of transcriptome sequencing.
Sample ID Clean Reads Pairs Clean base(bp) Q30(%) Total mapped ratio
L-C-1 20,293,546 6,088,063,800 94.10 88.18%
L-C-2 20,985,943 6,295,782,900 93.90 88.13%
L-C-3 23,912,399 7,173,719,700 94.50 84.87%
L-30m-1 32,656,966 9,797,089,800 95.10 86.89%
L-30m-2 23,181,660 6,954,498,000 94.40 86.48%
L-30m-3 24,975,913 7,492,773,900 95.50 88.34%
L-60m-1 27,668,533 8,300,559,900 95.10 81.33%
L-60m-2 29,805,125 8,941,537,500 95.00 83.18%
L-60m-3 25,126,846 7,538,053,800 95.00 80.27%
R-C-1 29,744,172 8,923,251,600 94.50 83.81%
R-C-2 23,816,503 7,144,950,900 94.50 84.79%
R-C-3 32,709,317 9,812,795,100 94.40 85.04%
R-30m-1 28,947,683 8,684,304,900 94.10 87.06%
R-30m-2 27,988,337 8,396,501,100 94.20 82.97%
R-30m-3 32,120,101 9,636,030,300 94.30 81.86%
R-60m-1 32,180,957 9,654,287,100 94.80 86.13%
R-60m-2 31,520,243 9,456,072,900 94.20 81.40%
R-60m-3 26,093,048 7,827,914,400 94.0 0 86.81%
Fig 1. PCA in hepatopancreas and ovary and DEGs in hepatopancreas.

Fig 1

(A) PCA showed differences between the untreated groups (C) and the treated groups (30 m, 60 m) in hepatopancreas and ovary. (B) DEGs generated between C vs. 30 min and C vs. 60 min in hepatopancreas, as well as venns and heatmaps generated between C vs. 30 min and C vs. 60 min.

Analysis of differentially expressed genes

Differentially expressed genes (DEGs) defined by fold change (FC) ≥ 2 and FDR < 0.01 reflected the gene expression patterns between different sample groups, therefore, providing some explanations for the body’s response within 1 hour of AFB1 stress. In hepatopancreas and ovaries, AFB1 for 30 minutes and 45 minutes groups were compared with control group, respectively. Specifically, we performed the conventional analysis of the pairwise comparisons of C vs. 30 min and C vs. 60 min in hepatopancreas and ovaries, respectively. Results showed, 210 (133 up-regulated; 77 down-regulated) and 250 (140 up-regulated; 110 down-regulated) DEGs were identified in the L-C vs. L-30 m and L-C vs. L-60 m comparison in hepatopancreas, respectively. Further analysis revealed 64 DEGs were the same in L-C vs. L-30 m and L-C vs. L-60 m comparison, with 34 DEGs up-regulated and 30 DEGs down-regulated (Fig 1B, S1 and S2 Tables). The 34 common up-regulated DEGs mentioned above had attracted our attention, guiding us to understand which genes were more active and which functions were enhanced after stress (Fig 1B). Studies had found that 14 up-regulated DEGs showed relatively complete functional annotation information or biological function related to this study (S3 Table). Based on the relevant gene annotations and functional gene research reports in the literature, we had simply classified the above 14 DEGs into six categories of functions, including antibacterial and detoxification, ATP energy reaction, redox reaction, nerve reaction, liver injury repair, and immune reaction. Among them, five DEGs were related to antibacterial and detoxification, followed by two DEGs related to ATP energy reaction, redox reaction, nerve reaction, and liver injury repair, and one DEG related to immune reaction (Fig 2). The log2FC values of 14 DEGs ranged from 1.35 to 21.11, and the log2FC values of same gene between L-C vs. L-30 m and L-C vs. L-60 m was not significantly different, indicating that the possibility of individual differences leading to differential genes was very small (Fig 2). Literature showed that gene LOC127005969 (PRSS1_2_3) encoded trypsin-like serine proteinase and played an important role in the repair of pathological processes such as coagulation, immune response, fibrinolysis, inflammation and tumor [25]. The log2FC values of gene LOC127005969 were 5.18 (L-C vs. L-30 m) and 4.83 (L-C vs. L-60 m), showing a significant increase in the treated group compared with the untreated group. Gene LOC126998993 (SORD) encoded sorbitol dehydrogenase, and high expression of this protein indicated a signal of liver injury [26]. The expression level of LOC126998993 increased nearly fourfold before and after treatment (the log2FC values of 1.96 in L-C vs. L-30 m and 1.77 in L-C vs. L-60 m, respectively). Gene LOC127004138 could encode anti-lipopolysaccharide factor, which was widely used in aquaculture due to its strong antibacterial activity and broad antibacterial spectrum [27]. The expression level of LOC127004138 increased more than fourfold before and after treatment (the log2FC values of 2.12 in L-C vs. L-30 m and 2.84 in L-C vs. L-60 m, respectively). Additionally, the increased expression of several proteases or enzymes reflects the enhanced detoxification ability of hepatopancreas to cope with the invasion of AFB1, such as lipid-transfer protein encoded by gene LOC127005812 (SCP2); arylsulfatase encoded by gene LOC126986919 (ARSB); hormone esterase encoded by gene LOC127004133 and copper-specific metallothionein encoded by gene LOC126997672. All these proteins had been reported to be associated with detoxification [28], and in this study, the expression levels of these genes in the treated group increased by at least two times compared to the untreated group. In addition to these genes mentioned above, we also studied and analyzed other biological activities, such as redox reactions, neural reactions, and energy activities.

Fig 2. Six categories of functions were classified by 14 DEGs, with Log2FC in C vs. 30 min and C vs. 60 min.

Fig 2

In the ovaries, 124 (45 up-regulated; 79 down-regulated) and 99 (68 up-regulated; 31 down-regulated) DEGs were identified in the comparison of R-C vs. R-30 m and R-C vs. R-60 m, respectively (Fig 3A). The 124 and 99 DEGs mentioned above have a total of 12 shared DEGs, of which 7 DEGs were up-regulated and 5 DEGs were down-regulated (Fig 3B, S4 Table). NR annotation indicated most of DEGs were associated with proteins that have not been characterized or hypothesized. Only four genes (LOC127003043; novel.27046; novel.898; LOC127005871) were annotated in GO terminology, and GO explained the function of these genes as integral component of membrane. In the experiment on the ovaries, there were no characteristic DEGs presented, which reflected that within 1 hour of AFB1 invasion, the stress response activity of the ovaries was much less intense than that of the hepatopancreas.

Fig 3. DEGs generated in ovary.

Fig 3

(A) Volcanic maps of DEGs generated by C vs. 30 min and C vs. 60 min in the ovaries. (B) venns and heatmaps generated between C vs. 30 min and C vs. 60 min in ovary.

K-means analysis in hepatopancreas

To decipher the overall trend in gene expression profiles, k-means clustering method was applied to determine the trend change of DEGs in hepatopancreas. We subjected 318 DEGs in hepatopancreas to k-means clustering process and obtained five distinct subclusters (Fig 4). As a result, subcluster 2 revealed that the expression levels of 49 DEGs decreased after 30 minutes and remained basically unchanged from 30 minutes to 60 minutes. Subcluster 3 revealed the expression levels of 61 DEGs continued to increase from the beginning to 60 minutes. The expression levels of 44 DEGs showed a trend of first decreasing and then increasing from 30 minutes to 60 minutes (subcluster 1), while 23 DEGs first increased and then decreased from 30 minutes to 60 minutes (subcluster 5).

Fig 4. K-means analysis of hepatopancreas.

Fig 4

Metabolomics analysis

Analysis of metabolites based on UPLC-MS/MS-based quantitative

To further explore the reactions in hepatopancreas and ovary within 1 hour after injection of AFB1 standard solution, an untargeted metabolomics method were used to detect metabolite compounds and investigate differential metabolites produced in the pairwise comparisons. In this study, a total of 13,963 metabolites were detected or identified, of which 6,642 were positive model and 7,321 were negative model. The number of metabolites for secondary identification was 4,829 in positive model and 4,003 in negative model, so we selected metabolites from positive model for subsequent analysis. Statistical analysis revealed that the components of metabolites were classified into 25 major categories, with amino acid and its metabolites accounting for 27.33%, followed by benzene and substituted derivatives (12.41%), and heterocyclic compounds (11.4%)(Fig 5A). The differential metabolites were searched by the model for orthogonal partial least squares discriminant analysis (OPLSDA), which performed 200 random permutations and combination experiments on the data. The OPLSDA results show that the model parameters for R2Y and Q2 values were close to 1, further verifying the reliability of the OPLSDA Model (S1 and S2 Figs).

Fig 5. Characteristics of metabolites and DAMs in hepatopancreas.

Fig 5

(A) 25 major categories were classified by metabolites. (B) The OPLS-DA model showed significant differences between the untreated groups (C) and the treated groups (30 m, 60 m) in hepatopancreas. (C) Volcanic maps of DAMs generated by C vs. 30 min and C vs. 60 min in hepatopancreas.

Functional annotation and enrichment analysis of differential metabolites

Combined with the multivariate analysis of OPLS-DA, the variable importance projection (VIP) > 1 together with fold change ≥2 or ≤0.5, was used as the screening criteria for differential abundant metabolites. In a hepatopancreatic positive model, group using the blank working solution (ML-C) was compared with groups using the standard AFB1 working solution (ML-30 m and ML-60 m), resulting the differentially accumulated metabolites (DAMs). The OPLS-DA model maximized the discrimination between group using the blank working solution (ML-C) and groups using the standard AFB1 working solution (ML-30 m and ML-60 m), showing significant differences (Fig 5B). In the comparison between ML-C and ML-30 m, a total of 228 metabolites (133 up-regulated and 95 down-regulated) showed significant differences. A total of 401 metabolites (339 up-regulated and 62 down-regulated) were identified as DAMs in the ML-C vs. ML-60 m comparison (Fig 5C). According to the functional annotation of DAM, based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, 25 and 31 pathways were enriched in the comparison of ML-C vs. ML-30 m and ML-C vs. ML-60 m, respectively (S5 and S6 Tables). KEGG pathway analysis founded they both enriched a total of 12 pathways, with clear functions of cutin, suberine and wax biosynthesis; tyrosine metabolism; purine metabolism; nucleotide metabolism; glycine, serine and threonine metabolism; ABC transporters and tryptophan metabolism. The significant enrichment pathways (P<0.05) in comparison between ML-C and ML-30 m were cyanoamino acid metabolism (ko00460), glutathione metabolism(ko00480) and sulfur relay system(ko04122) (Fig 6A). More specifically, N-hydroxy-L-isoleucine (MW0154477) and N-hydroxy-L-valine (MW0154482), as members of amino acid and its metabolites, were DAMs in the ML-C vs. ML-30 m comparison and participated in the ko00460 pathway. In addition, gamma-glutamylalanine (MW0106760) and cadaverine (MW0110603) participated in the ko00480 pathway, and thiamine (MEDP0514) participated in the ko04122 pathway. In order to understand the synergistic or mutually exclusive relationship between different metabolites, the interactions between the top 50 differential metabolites were subjected to process by the Pearson correlation analysis method. The results showed that amino acid and its metabolites accounted for the highest proportion, with a total of 17 DAM members (Fig 6D).

Fig 6. Enrichment analysis of KEGG pathway and pearson correlation analysis of the top 50 differential metabolites in hepatopancreas and ovaries.

Fig 6

(A) Enrichment analysis of KEGG pathway for C vs. 30 min in hepatopancreas. (B) Enrichment analysis of KEGG pathway for C vs. 60 min in hepatopancreas. (C) Enrichment analysis of KEGG pathway for C vs. 60 min in ovary. (D) Pearson correlation analysis of the top 50 differential metabolites for C vs. 30 min in hepatopancreas. (E) Pearson correlation analysis of the top 50 differential metabolites for C vs. 60 min in hepatopancreas. (F) Pearson correlation analysis of the top 50 differential metabolites for C vs. 60 min in ovary.

The significantly enrichment pathways (P<0.05) in ML-C vs. ML-60 m comparison were sphingolipid metabolism (ko00600) (Fig 6B). Sphinganine(MW0111287),N-(dodecanoyl)-sphing-4-enine-1-phosphocholine (MW0055323) and phytosphingosine (MEDP1685), as members of sphingolipids (SL), were DAMs in ML-C vs. ML-60 m comparison and participated in the ko00600 pathway. The top 50 differential metabolites contained ten kinds of amino acid and its metabolites, seven kinds of fatty acyls (FA), and six kinds of benzene and substituted derivatives (Fig 6E).

In the ovarian positive model, group using the blank working solution (MR-C) in the ovaries was compared with groups using the standard AFB1 working solution (MR-30 m and MR-60 m), generating 262 (145 up-regulated and 117 down-regulated) and 452 (91 up-regulated and 361 down-regulated) differential metabolites in the comparison of MR-C vs. MR-30 m and MR-C vs. MR-60 m, respectively. In the comparison between MR-C and MR-30 m, no significant enrichment pathways were found in the 36 enriched KEGG pathways (P<0.05), while in the comparison between MR-C and MR-60 m, 10 significantly enriched KEGG pathways (P<0.05) were found in the 66 enriched KEGG pathways, including 2-oxocarboxylic acid metabolism, tropane, piperidine and pyridine alkaloid biosynthesis, glucosinolate biosynthesis, flavonoid biosynthesis, phenylalanine metabolism, aminoacyl-tRNA biosynthesis, D-amino acid metabolism, fatty acid biosynthesis, and cysteine and methionine metabolism (Fig 6C). The top 50 differential metabolites contained 11 kinds of benzene and substituted derivatives, followed by 10 kinds of amino acid and its metabolites (Fig 6F).

Integrated analysis of metabolomics and transcriptomics

The comprehensive analysis of metabolomics and transcriptome could systematically study the coordinated response of crabs to AFB1 stress. The combined data of multiple genomics could further analyze the interaction between genes and metabolites, so as to analyze and deal with this stress response. According to the data of metabolomics and transcriptomics, the DEGs and DAMs derived from the comparisons of ML-C vs. ML-30 m and ML-C vs. ML-60 m were Co-enriched and analyzed. The results showed that in ML-C and ML-30 m, 11 DEGs and 12 DAMs, were Co-enriched into 7 pathways in KEGG enrichment pathways (S7 Table); in the comparison between ML-C and ML-60 m, 17 DEGs and 19 DAMs Co-enriched into 9 pathways (S8 Table). Among the 7 and 9 pathways mentioned above, there are four pathways, including glycine, serine and threonine metabolism, tryptophan metabolism, tyrosine metabolism and purine metabolism, which were shared by both (Fig 7A). In order to further explore the role of genes and metabolites in the same pathway, we anchored the up-regulated DEGs and DAMs at specific locations and studied their interactions. From certain positions in the three pathways of steroid biosynthesis (ko00100), glycine, serine and threonine metabolism (ko00260), and sphingolipid metabolism (ko00600), there were up-regulated DEG and DAM involved in co- regulation, which had caught our attention. In steroid biosynthesis (ko00100) pathway, enzyme sterols were products of transcription-translation and modification by gene LOC127008729 (EGR3), which catalyzed the conversion of episterol into ergostathenol (Fig 7B). Ergostathenol was converted to ergostatetraenol (C05440) under a action of the isoenzymes of EGR, and then into ergosterol. Ergosterol, as an important source of fat-soluble vitamin D2, had significant antibacterial and anti-tumor effects [29, 30]. In this pathway, the mean FPKM of DEG EGR3 in the L-C group and L-30m group were 16.40 and 40.08, respectively. The expression level of DAM MW0148978 (C05440) significantly increased from ML-C stage to ML-30 m stage and showed differences. The second ko00260 pathway showed that DEG LOC126981425 (SARDH) encoded sarcosine dehydrogenase, which catalyzed of sarcosine to glycine (Fig 7C). Recent studies have found that the mechanisms of glycine included physiological protection against ischemia reperfusion injury, shock, transplantation, alcoholic hepatitis, liver fibrosis, arthritis, tumor, and drug toxicity, as well as anti-inflammatory and immunomodulatory effects [31, 32]. A portion of glycine was involved in clyoxylate metabolism, and the other portion was converted to guanidinoacetate (C00581) under the action of GATM, ultimately converting to creatine and entering arginine and proline metabolism. Creatine contributed to the circulation of adenosine triphosphate (ATP), thereby facilitating energy supply to muscles and the brain. Arginine could promote cell proliferation, improve animal growth performance, enhance immunity and antioxidant capacity [33, 34]. The mean FPKM of DEG SARDH in the L-C group and L-60m group were 0.96 and 7.05, respectively, indicating that the expression response of this gene after stress was quite intense. Meanwhile, the expression level of DAM MW0107125 (C00581) also sharply increased in the ML-60 m group compared to ML-C group. The third ko00600 pathway showed that DEG LOC126997840 (GBA,srfJ) was a highly expressed gene in the untreated group (L-C), with an average FPKM of 117.93. However, in the 60 minute treatment group (L-60 m), the mean FPKM was as high as 716.67, indicating a significant change in the expression level of this gene after stress. The expression levels of DAM C00195, MW0111287 (C00836), MEDP1685 (C12144) and MW0055323 (C00550) co-expressed in this pathway also significantly increased after 60 minutes of treatment (Fig 7D). Phytosphingosine (C12144), as the precursor of ceramide (C00195), was a natural broad-spectrum antibacterial agent. Sphingomyelin (C00550) regulated immune function and inflammatory reaction, and participated in oxidative stress reaction [35]. Many cellular stress inducers, such as inflammatory activation, excessive saturated fatty acid intake, and chemotherapy, could lead to an increase in the rate of ceramide (C00195) synthesis [36, 37].

Fig 7. KEGG pathways Co-enriched by DEGs and DAMs and interaction signals generated by up-regulated DEGs and DAMs.

Fig 7

(A) KEGG pathways Co-enriched by DEGs and DAMs between the comparison of C vs. 30 min and C vs. 60 min in hepatopancreas. (B) Interaction signals at specific local locations in steroid biosynthesis pathway. (C) The interaction signals at specific local locations in glycine, serine and threonine metabolism. (D) The interaction signals at specific local locations in sphingolipid metabolism.

Discussion

In this study, we integrated transcriptomics and metabolomics analysis of hepatopancreas and ovary, and looked for the regulatory mechanism of Eriocheir sinensis’s adaptability to aflatoxin B1 from the perspective of differential expression of genes and metabolites. DEGs and DAMs revealed the differential response between groups without AFB1 and groups with AFB1, which helps us analyze and manage this stress response. Transcriptomics results showed that a series of complex changes occurred in hepatopancreas and ovary within one hour after AFB1 injection. The hepatopancreas, as an immune and detoxifying organ, has a natural response to AFB1, as evidenced by changes in the expression of many functional genes. However, we did not find this strong response in the ovaries. We speculate that within one hour of being invaded by AFB1 in crabs, the hepatopancreas have already participated in various regulatory responses to cope with this stress, while the ovaries are not the main response organs during this period, and their responses are not very sensitive.

Compare the blank working solution groups (L-C) and standard AFB1 working solution groups (L-30 m and L-60 m) in hepatopancreas, and annotate the generated DEGs into GO, KEGG, and NR databases, respectively, to screen the target genes as the focus of this study. The hepatopancreas is the main detoxifying organ and the main site for material metabolism and transformation, making it highly susceptible to damage from toxic substances [3]. According to reports, AFB1 induced hepatopancreatic injury is mainly mediated by four mechanisms: CYP450 enzyme, mitochondria, immune system, and free radicals [38]. In our sequencing results, we found that the gene novel.6517 and the gene LOC126984017 (UGT) were associated with the synthesis of eytoehrome P450. Gene novel.6517 encoded NADPH—cytochrome P450 reductase, with an mean FPKM of 0.01 and 2.50 in the L-C and L-60 m groups, respectively. The mean FPKM of gene LOC126984017 (UGT) in L-C group and L-30m group were 18.30 and 65.73, respectively, and it is involved in the metabolism of xenobiotics and drug by cytochrome P450. The abnormal increase in the expression levels of these two genes indirectly indicates that P450 enzymes are more active in response during stress.

Further systematic analysis showed there were 64 identical DEGs in the comparison between L-C vs. L-30 m and L-C vs. L-60 m, of which 34 identical DEGs were up-regulated. Based on functional annotation information and literature reports, we dissected 14 DEGs and classified them into six categories of functions, including antibacterial and detoxification, ATP energy reaction, redox reaction, nerve reaction, liver injury repair and immune reaction. According to reports, AFB1 induced immune toxicity reactions may lead to dysfunction of oxidative stress function [39]. During this process, we discovered two DEGs (LOC126981104, LOC126981425) associated with oxidative reactions and one DEG (LOC127005969) associated with immune responses, indicating that AFB1 can cause an increase in the expression of redox related genes, thus supporting the viewpoint reported in the above literature. In practical applications, antioxidants can be added to animal feed to protect and prevent AFB1 poisoning in livestock and poultry by enhancing antioxidant capacity and immune function [40]. The literature indicates that an increase in the expression levels of two DEGs (LOC126998993, novel.4226) indicates liver injury, indicating that these two genes have an self-evident repair effect on liver tissue [26]. The abnormal expression of four hydrolytic enzymes related to regulatory effects encoded by DEGs (LOC127004133, LOC127005812, LOC126997672, LOC127004138) is related to the antibacterial and detoxification of the liver, and has also been mentioned in the literature [27, 28]. Additionally, DEGs are also involved in neuromodulation and energy response, which are also synergistic reactions of hepatopancreas after stress.

The results of the metabolomics showed a total of 12 pathways were enriched in the comparison between ML-C vs. ML-30 m and ML-C vs. ML-60 m. Among them, cyanoamino acid metabolism (ko00460), glutathione metabolism(ko00480), sulfur relay system(ko04122) and sphingolipid metabolism (ko00600) were significantly enriched (P<0.05). Two DAMs (MW0106760, MW0110603) were involved in the glutathione metabolism, which has been reported to have antioxidant, immune, and detoxifying properties effects [41]. Three DAMs(MW0111287, MW0055323, MEDP1685) were involved in the sphingolipid metabolism, and sphingolipids have been reported to involved in many important signal transduction processes, including regulating cell growth, differentiation, aging, and programmed cell death [42]. From the above enrichment analysis results, it can be inferred that the expression of metabolites in hepatopancreas is also actively responding to AFB1 stress.

The Co-enriched pathways of metabolomics and transcriptomics were subjected to explore the interaction mechanism between them. The seven pathways Co-enriched by DEGs and DAMs between the untreated group (C) and the 30 min treat groups (30 m) and the nine pathways Co-enriched by DEGs and DAMs between the untreated group (C) and the 60 min treat groups (60 m) shared four identical pathways, including glycine, serine and threonine metabolism, tryptophan metabolism, tyrosine metabolism and purine metabolism. The metabolic enrichment of the above three amino acids reflects the synergistic response and consistent regulation of DEG and DAM when the hepatopancreas faces AFB1 stress. These feedbacks provide good research ideas and directions for future research on this stress regulation, especially in the discovery of important functions in the glycine, serine and threonine metabolism. DEGs and DAMs involved in this pathway are up-regulated, which will be further studied in detail in the following discussion. We anchored the up-regulated DEGs and DAMs on the KEGG map and depicted their interaction relationship on the map. Three interaction signals were generated from specific positions on the KEGG maps, including steroid biosynthesis (ko00100), glycine, serine and threonine metabolism (ko00260), and sphingolipid metabolism (ko00600).

In steroid biosynthesis, ergosterol is produced through the actions of DEG LOC127008729 (EGR3) and DAM MW0148978 (C05440), which are reaction enzyme and substrate on the KEGG map, respectively. Ergosterol is an important component of fungal cell membranes and plays an important role in ensuring the integrity of membrane structure. Ergosterol can significantly inhibit tumor growth and activate inhibitory genes, therefore demonstrating a strong antibacterial ability. Research has shown that it can also enhance immune function and convert into fat soluble vitamin D2 [29, 30]. In the metabolism of glycine, serine, and threonine, DEG LOC126981425 (SARDH) encodes sarcosine dehydrogenase, which is an important catalytic enzyme for the production of glycine. Glycine has anti-inflammatory and immunomodulatory effects, and literature has shown that it has physiological protective effects on liver injury and hepatitis [31, 32]. The metabolite guanidinoacetate represented by MW0107125 (C00581) on KEGG map will ultimately be converted into creatine, which then converts into arginine and proline metabolites. According to reports, arginine can improve animal growth performance, enhance immunity and antioxidant capacity. Therefore, it is often used as a feed additive, with effects such as wound healing, ammonia excretion, immune function, and hormone secretion [33, 34]. The synergistic up-regulation of LOC126981425 (SARDH) and MW0107125 (C00581) in this pathway, combined with their functions, can infer the regulatory response and protective mechanism played by the hepatopancreas in crabs. In sphingolipid metabolism, the metabolites dihydrosphingosine, phytosphingosine, sphingomyelin and ceramide were all detected as DAMs on the ko00600 map. They can transform into each other under certain conditions. phytosphingosine is produced as a natural broad-spectrum antibacterial agent; sphingomyelin and ceramide could regulate immune function, inflammatory reaction and oxidative stress reaction [3537]. The function of these DAMs can also indicate an enhancement of hepatopancreatic sphingolipids metabolism to resist the invasion of AFB1.

This study explored genes or metabolites related to antibacterial activity, redox ability, liver injury protection, immune enhancement, and anti-inflammatory repair by combining target functional genes, metabolites, and metabolic pathways screened by multiple omics. These genes and metabolites play an important role in responding to the invasion of AFB1 in the hepatopancreas or ovaries of crabs. This experiment provides us with valuable insights into the molecular mechanism of the response of crab hepatopancreas to AFB1, and provides direction and ideas for future guidance in addressing AFB1 damage to crabs.

Supporting information

S1 Fig. The OPLS-DA model validation in ML-C vs. ML-30m comparison.

(TIF)

S2 Fig. The OPLS-DA model validation in ML-C vs. ML-60m comparison.

(TIF)

S1 Table. Up-regulated DEGs in comparison between L-C vs. L-30m and L-C vs. L-60m.

(XLSX)

S2 Table. Down-regulated DEGs in comparison between L-C vs. L-30m and L-C vs. L-60m.

(XLSX)

S3 Table. Cored and up-regulated DEGs during AFB1 injection in hepatopancreas.

(DOCX)

S4 Table. DEGs in comparison between R-C vs. R-30m and R-C vs. R-60m.

(XLSX)

S5 Table. KEGG pathways were enriched by DAMs in ML-C vs. ML-30m comparison.

(XLSX)

S6 Table. KEGG pathways were enriched by DAMs in ML-C vs. ML-60m comparison.

(XLSX)

S7 Table. KEGG pathways were Co-enriched by DEGs and DAMs in C vs. 30 m comparison.

(DOCX)

S8 Table. KEGG pathways were Co-enriched by DEGs and DAMs in C vs. 60 m comparison.

(DOCX)

Acknowledgments

The experimental design and data analysis of this article were guided by Professor Yifeng Li from College of Aquatic and Life Sciences, Shanghai Ocean University; Yitian technologiescorporation provided experimental equipment and materials for this experiment.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Wang J S, Groopman J D. DNA damage by mycotoxins. Mutat Res. 1999;424(1–2):167–81. doi: 10.1016/s0027-5107(99)00017-2 . [DOI] [PubMed] [Google Scholar]
  • 2.Wang J S, Huang T, Su J, Liang F, Wei Z, Liang Y, et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People’s Republic of China. Cancer Epidemiol Biomarkers Prev. 2001;10(2):143–146. . [PubMed] [Google Scholar]
  • 3.Wang L Y, Hatch M, Chen C J, Levin B, You S L, Lu S N, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer. 1996;67(5):620–625. doi: . [DOI] [PubMed] [Google Scholar]
  • 4.Schoenhard G L, Hendricks J D, Nixon J E, Lee D J, Wales J H, Sinnhuber R O, et al. Aflatoxicol-induced hepatocellular carcinoma in rainbow trout (Salmo gairdneri) and the synergistic effects of cyclopropenoid fatty acids. Cancer Res. 1981;41(3):1011–1014. . [PubMed] [Google Scholar]
  • 5.Chen H Y, Rawlings R. The truth of mycotoxin contamination of feed in Asia region. China Poultry, 2018;30(16): 33–35. [Google Scholar]
  • 6.Wang G Q, Liu Y D, Duan S H. Mycotoxin contamination and investigation of feed and feedstuff in the first half of 2019. Swine Production. 2019;(6): 17–19. [Google Scholar]
  • 7.Deng S X, Tian L X, Liu F J, Jin S J, Liang G Y, Yang H J, et al. Toxic effects and residue of aflatoxin B1 in tilapia (Oreochromis niloticus×O. aureus). Aquaculture. 2010;307(3–4):233–240. doi: 10.1016/j.aquaculture.2010.07.029 [DOI] [Google Scholar]
  • 8.Ngethe S, Horsberg T E, Mitema E, Ingebrigtsen K. Species differences in hepatic concentration of orally administered 3H AFB1 between rainbow trout (Oncorhynchus mykiss) and tilapia (Oreochromis niloticus). Aquaculture. 1993;114(3–4): 355–358. doi: 10.1016/0044-8486(93)90309-m [DOI] [Google Scholar]
  • 9.Halver J E. Aflatoxicosis and trout hepatoma. In: Goldblatt L A (Eds.), Aflatoxin: Scientific Background, Control, and Implications. Aflatoxin. 1969;147(05):265–306. doi: 10.1111/j.0954-6820.1953.tb16245.x [DOI] [Google Scholar]
  • 10.Yu Y Y, Niu J, Yin P, Mei X T, Liu Y J, Tian L X, et al. Detoxification and immunoprotection of Zn(II)-curcumin in juvenile Pacific white shrimp (Litopenaeus vannamei) feed with aflatoxin B1. Fish Shellfish Immunol. 2018;80:480–486. doi: 10.1016/j.fsi.2018.05.034 . [DOI] [PubMed] [Google Scholar]
  • 11.Plakas S M, Loveland P M, Bailey G S, Blazer V S, Wilson G L. Tissue disposition and excretion of 14C-labelled aflatoxin B1 after oral administration in channel catfish. Food Chem Toxicol. 1991;29(12):805–808. doi: 10.1016/0278-6915(91)90106-h . [DOI] [PubMed] [Google Scholar]
  • 12.Sahoo P K, Mukherjee S C. Immunosuppressive effects of aflatoxin B1 in Indian major carp (Labeo rohita). Comp Immunol Microbiol Infect Dis. 2001;24(3):143–9. doi: 10.1016/s0147-9571(00)00017-5 . [DOI] [PubMed] [Google Scholar]
  • 13.El-Banna R, Teleb H M, Hadi M M. Performance and tissue residue of tilapia fed dietary aflatoxin. Veterinary Medical Journal Giza. 1992; 40: 17–23. [Google Scholar]
  • 14.Huang Y, Han D, Xiao X, Zhu X, Yang Y, Chen Y, et al. Effect of dietary aflatoxin B1, on growth, fecundity and tissue accumulation in gibel carp during the stage of gonad development. Aquaculture. 2014; 428-429(5): 236–242. doi: 10.1016/j.aquaculture.2014.03.010 [DOI] [Google Scholar]
  • 15.Jantrarotai W, Lovell R T. Subchronic toxicity of dietary aflatoxin B1 to channel catfish. Journal of Aquatic Animal Health. 1990; 2(4): 248–254. doi: 10.1577/1548-8667(1990)0022.3.CO;2 [DOI] [Google Scholar]
  • 16.Sahoo P K, Mukherjef S C, Jain A K, Mukherjee A. Histopathological and electron microscopic studies of gills and opisthonephros of rohu, Labeo rohita to acute and subchronic aflatoxin B1 toxicity. Asian Fisheries Science. 2003;16(3–4): 257–268. [Google Scholar]
  • 17.Rui A G, Tu D C, Nguyen N T, Santos G A, Encarnao P, Hung L T, et al. Aflatoxin B1 (AFB1) reduces growth performance, physiological response, and disease resistance in Tra catfish (Pangasius hypophthalmus). Aquaculture International. 2018;26(3): 921–936. doi: 10.1007/s10499-018-0259-x [DOI] [Google Scholar]
  • 18.Zeng S L, Long W Q, Tian L X, Xie W S, Chen J Y. Effects of dietary aflatoxin B1 on growth performance, body composition, haematological parameters and histopathology of juvenile Pacific white shrimp (Litopenaeus vannamei). Aquaculture Nutrition. 2016;22(5): 1152–1159. doi: 10.1111/anu.12331 [DOI] [Google Scholar]
  • 19.Chen S, Liu Y, Xie S, Guo Y, Yang H, Wei Y, et al. Role of myo-inositol supplementation against toxicity of excessive dietary copper in Pacific white shrimp Litopenaeus vannamei. Ecotoxicol Environ Saf. 2022;241:113712. doi: 10.1016/j.ecoenv.2022.113712 . [DOI] [PubMed] [Google Scholar]
  • 20.Tang B, Zhou K, Song D, Yang G, Dai A. Molecular systematics of the Asian mitten crabs, genus Eriocheir (Crustacea: Brachyura). Mol Phylogenet Evol. 2003;29(2):309–16. doi: 10.1016/s1055-7903(03)00112-x . [DOI] [PubMed] [Google Scholar]
  • 21.Wang W, Wen B, Gasparich G E, Zhu N, Rong L, Chen J, et al. A spiroplasma associated with tremor disease in the Chinese mitten crab (Eriocheir sinensis). Microbiology (Reading). 2004;150(Pt 9):3035–3040. doi: 10.1099/mic.0.26664-0 . [DOI] [PubMed] [Google Scholar]
  • 22.Kim D, Langmead B, Salzberg S L. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–60. doi: 10.1038/nmeth.3317 ; PMCID: PMC4655817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pertea M, Pertea G M, Antonescu C M, Chang T C, Mendell J T, Salzberg S L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290–295. doi: 10.1038/nbt.3122 ; PMCID: PMC4643835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.He C, Liu X, Teixeira da Silva JA, Liu N, Zhang M, Duan J. Transcriptome sequencing and metabolite profiling analyses provide comprehensive insight into molecular mechanisms of flower development in Dendrobium officinale (Orchidaceae). Plant Mol Biol. 2020;104(4–5):529–548. doi: 10.1007/s11103-020-01058-z . [DOI] [PubMed] [Google Scholar]
  • 25.Gao R, Yong Z, Gopalakrishnakone P. A novel trypsin-like serine proteinase from the venom of the chinese scorpion buthus martensii karsch. Ifmbe Proceedings. 2008;21(1):829–832. doi: 10.1007/978-3-540-69139-6_206 [DOI] [Google Scholar]
  • 26.El-Kabbani O, Darmanin C, Chung R P. Sorbitol dehydrogenase: structure, function and ligand design. Curr Med Chem. 2004;11(4):465–76. doi: 10.2174/0929867043455927 . [DOI] [PubMed] [Google Scholar]
  • 27.Andrä J, Lamata M, Martinez de Tejada G, Bartels R, Koch MH, Brandenburg K. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Biochem Pharmacol. 2004;68(7):1297–307. doi: 10.1016/j.bcp.2004.05.054 . [DOI] [PubMed] [Google Scholar]
  • 28.Milligan S, Martin G G, Landrock D, McIntosh A L, Mackie J T, Schroeder F, et al. Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(3):291–304. doi: 10.1016/j.bbalip.2016.12.002 ; PMCID: PMC5266609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hashim S N, Schwarz L J, Danylec B, Mitri K, Yang Y, Boysen RI, et al. Recovery of ergosterol from the medicinal mushroom, Ganoderma tsugae var. Janniae, with a molecularly imprinted polymer derived from a cleavable monomer-template composite. J Chromatogr A. 2016;1468:1–9. doi: 10.1016/j.chroma.2016.09.004 . [DOI] [PubMed] [Google Scholar]
  • 30.Krumpe K, Frumkin I, Herzig Y, Rimon N, Özbalci C, Brügger B, et al. Ergosterol content specifies targeting of tail-anchored proteins to mitochondrial outer membranes. Mol Biol Cell. 2012;23(20):3927–35. doi: 10.1091/mbc.E11-12-0994 ; PMCID: PMC3469509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Li X, Bradford B U, Wheeler M D, Stimpson S A, Pink H M, Brodie T A, et al. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel. Infect Immun. 2001;69(9):5883–5891. doi: 10.1128/IAI.69.9.5883-5891.2001 ; PMCID: PMC98707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ikejima K, Qu W, Stachlewitz R F, Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol. 1997;272(6 Pt 1):G1581–6. doi: 10.1152/ajpgi.1997.272.6.G1581 . [DOI] [PubMed] [Google Scholar]
  • 33.Scaglia F, Brunetti-Pierri N, Kleppe S, Marini J, Carter S, Garlick P, et al. Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. The Journal of Nutrition. 2004;134(10):775–782. doi: 10.1093/jn/134.10.2775S . [DOI] [PubMed] [Google Scholar]
  • 34.Vissers Y L, Dejong C H, Luiking Y C, Fearon K C, von Meyenfeldt M F, Deutz N E. Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr. 2005;81(5):1142–6. doi: 10.1093/ajcn/81.5.1142 . [DOI] [PubMed] [Google Scholar]
  • 35.Grassi S, Mauri L, Prioni S, Cabitta L, Sonnino S, Prinetti A, et al. Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases. Front Pharmacol. 2019;23(10):807. doi: 10.3389/fphar.2019.00807 ; PMCID: PMC6689979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Czubowicz K, Jęśko H, Wencel P, Lukiw W J, Strosznajder R P. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders. Mol Neurobiol. 2019;56(8):5436–5455. doi: 10.1007/s12035-018-1448-3 ; PMCID: PMC6614129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cattaneo M G, Vanetti C, Samarani M, Aureli M, Bassi R, Sonnino S, et al. Cross-talk between sphingosine-1-phosphate and EGFR signaling pathways enhances human glioblastoma cell invasiveness. FEBS Lett. 2018;592(6):949–961. doi: 10.1002/1873-3468.13000 . [DOI] [PubMed] [Google Scholar]
  • 38.Giri, Indrajit, Stone. Wobble dC·dA Pairing 5′ to the Cationic Guanine N7 8,9-Dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B[sub 1] Adduct: Implications for Nontargeted AFB[sub 1] Mutagenesis. Biochemistry. 2003;42:7023–7034. [DOI] [PubMed] [Google Scholar]
  • 39.Chen J, Chen K, Yuan S, Peng X, Fang J, Wang F, et al. Effects of aflatoxin B1 on oxidative stress markers and apoptosis of spleens in broilers. Toxicol Ind Health. 2016;32(2):278–84. doi: 10.1177/0748233713500819 . [DOI] [PubMed] [Google Scholar]
  • 40.Zhang N Y, Qi M, Zhao L, Zhu M K, Guo J, Liu J, et al. Curcumin Prevents Aflatoxin B₁ Hepatoxicity by Inhibition of Cytochrome P450 Isozymes in Chick Liver. Toxins (Basel). 2016. 10;8(11):327. doi: 10.3390/toxins8110327 ; PMCID: PMC5127124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Grażyna Świderska-Kołacz J Klusek, Adam Kołątaj. The effect of exogenous GSH, GSSG and GST-E on glutathione concentration and activity of selected glutathione enzymes in the liver, kidney and muscle of mice. Animal Science Papers & Reports. 2007;25(2):111–117. doi: 10.1016/j.anireprosci.2006.02.005 [DOI] [Google Scholar]
  • 42.van Kruining D, Luo Q, van Echten-Deckert G, Mielke MM, Bowman A, Ellis S, et al. Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods. Adv Drug Deliv Rev. 2020;159:232–244. doi: 10.1016/j.addr.2020.04.009 ; PMCID: PMC7665829. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Amel Mohamed El Asely

5 Oct 2023

PONE-D-23-23404Transcriptome and metabolomics analysis of adaptive mechanism of Chinese mitten crab (Eriocheir sinensis) to aflatoxin B1PLOS ONE

Dear Dr. Zhu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Amel Mohamed El Asely

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This Study was supported in part by the 333 High-level Talent Training Project of Jiangsu Province (BRA2019093), the Jiangsu Independent Innovation Project of Agricultural Science and Technology (CX(19)3007), and the Jiangsu Modern Agricultural Industry Technology System Project (JATS[2022]371).”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 “The author(s) received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

5. We are unable to open your Supporting Information file [Supporting Information.rar and Figures.rar]. Please kindly revise as necessary and re-upload

6. Please include a copy of Tables 1-9 which you refer to in your text on page 27.

7. Please upload a copy of Figures 1-7, to which you refer in your text on page 28. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Grammatical and spelling mistakes

Alignment not proper

Scientific names should be in italics

Please change ul-µl throughout the manuscript

Comparison data, results, or references should be there in the Results section

Statistical data should be explained more properly

Line 48- Food and feed?

Line 58 and 59- Rewrite the sentence

Line 81- We hope? It is research work and if results are there then why expect?

Line 96 and Line 101- “certain amount”- Please mention the amount

Line 107-Line 109- After 30 minutes or 60 minutes? Give only one-time point

that was done for the experiment

Line111- “Frozen samples with liquid nitrogen”- Rewrite the sentence

Line 126- Different groups- Mention the groups

Line 139-Line 141-Rewrite the sentence-It is not clear

Line 149-Line 150- Rewrite the sentence-Not clear

Line 170-Line 173- Explain the statistical analysis in detail

Line 191- PC1 and PC2- What are these? Explain?

Line 201- Line 205- Break the sentences to make it more clear

Reviewer #2: The manuscript entitled “Transcriptome and metabolomics analysis of the adaptive mechanism of Chinese mitten crab (Eriocheir sinensis) to aflatoxin B1” is an interesting study and the authors have collected a unique dataset using a cutting-edge methodology. The paper is generally well-written and structured and is presented in an intelligible fashion written in Standard English. This is described in a technically sound piece of scientific research with data that supports the conclusions. Experiments were conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions are appropriately based on the data presented in an appropriate and rigorous statistical analysis.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Manuscript SSE3092023.docx

PLoS One. 2023 Dec 7;18(12):e0295291. doi: 10.1371/journal.pone.0295291.r002

Author response to Decision Letter 0


7 Nov 2023

To Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have made the necessary modifications according to the instructions.

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

We delete the ‘Funding Information’, and have received no specific funding for this work.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This Study was supported in part by the 333 High-level Talent Training Project of Jiangsu Province (BRA2019093), the Jiangsu Independent Innovation Project of Agricultural Science and Technology (CX(19)3007), and the Jiangsu Modern Agricultural Industry Technology System Project (JATS[2022]371).”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The author(s) received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

We have modified the acknowledgment section and added this sentence to the cover letter,“The author(s) received no specific funding for this work.”

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

We create a ORCID iD for the corresponding author. ID number: 0000-0002-8595-5783.

5. We are unable to open your Supporting Information file [Supporting Information.rar and Figures.rar]. Please kindly revise as necessary and re-upload

We have uploaded each figure and table separately.

6. Please include a copy of Tables 1-9 which you refer to in your text on page 27.

Sorry, the Tables were in the compressed package, [Supporting Information rar.] We have re uploaded the tables.

7. Please upload a copy of Figures 1-7, to which you refer in your text on page 28. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

Sorry, the Figures were in the compressed package, [Figures.rar.] We have re uploaded the Figures.

8.Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Not modified

To Reviewer #1

1.Grammatical and spelling mistakes

we check it and correct it

2.Scientific names should be in italics

species names, genes and other scientific names were italics in this revision.

Corrected.

3.Please change ul-µl throughout the manuscript

Corrected.

4.Comparison data, results, or references should be there in the Results section. Statistical data should be explained more properly

I'm sorry, I uploaded the figures and tables of the results to the website in a compressed package. However, for some reason, this file cannot be seen by you. This submission will upload each data result separately.

5.Line 48- Food and feed?

It mainly present in feed, delete “ food”.

6.Line 58 and 59- Rewrite the sentence

The effects of AFB1 on aquatic animals have been widely reported in many research articles both domestically and internationally, such as Oreochromis niloticus [7,8], Oncorhynchus mykiss [9], Litopenaeus vannamei [10], Lctalurus punctatus [11], Labeo rohita [12] and other species.

7.Line 81- We hope? It is research work and if results are there then why expect?

This sentence is not appropriate. We have changed it to “ we analyzed the obtained data in this experiments and explained some molecular response mechanism in the results.

8.Line 96 and Line 101- “certain amount”- Please mention the amount

Line 96: by weighing 6 mg of aflatoxin B1 standard and dissolving it with 100 ml of dimethyl sulfoxide

Line 101 : “More than 18 female experimental crabs”

9.Line 107-Line 109- After 30 minutes or 60 minutes? Give only one-time point that was done for the experiment

I rewrote this sentence. “The hepatopancreas and ovaries of experimental crabs injected with AFB1 in first group were taken out after 30 minutes, and those in the second group were taken out after 60 minutes”

10.Line111- “Frozen samples with liquid nitrogen”- Rewrite the sentence

The samples were frozen with liquid nitrogen and quickly stored in an ultra-low temperature refrigerator (-80℃)

11.Line 126- Different groups- Mention the groups

Correct into “the above three groups (one control and two treatments)”

12.Line 139-Line 141-Rewrite the sentence-It is not clear

The clean reads were aligned to the reference genome Chinese mitten crab (Eriocheir sinensis) (https://www.ncbi.nlm.nih.gov/assembly/GCF_024679095.1) using HISAT 2 software

13.Line 149-Line 150- Rewrite the sentence-Not clear

I rewrote this sentence: the screening criteria for DEGs was FDR < 0.05 and fold change ≥ 2.

14.Line 170-Line 173- Explain the statistical analysis in detail

I rewrote this sentence “The differential metabolites were screened by combining the differential multiple, P value of the t-test and VIP value of the OPLS-DA model, and the screening standard was FC > 1, P value < 0.05 and VIP > 1. ” T-test is the use of t-distribution theory to infer the probability of differences occurring. The screening of differential metabolites is usually based on the OPLS-DA model, and VIP is used to evaluate the importance of each metabolite in metabolomic data analysis of sample classification or prediction models, usually greater than 1.

15.Line 191- PC1 and PC2- What are these? Explain?

Principal Component Analysis (PCA) is the most widely used data dimensionality reduction algorithm. All features of the sample are reflected using two principal components, PC1 and PC2. The position relationship of samples on the coordinate axis reflects the similarity between samples. The closer the position is, the higher the similarity between the two samples. The numerical value represents the explanatory rate of variance, and the larger the numerical value, the more reliable the model is.

16.Line 201- Line 205- Break the sentences to make it more clear

I rewrote this sentence “In hepatopancreas and ovaries,AFB1 for 30 minutes and 45 minutes groups were compared with control group, respectively.”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Amel Mohamed El Asely

20 Nov 2023

Transcriptome and metabolomics analysis of adaptive mechanism of Chinese mitten crab (Eriocheir sinensis) to aflatoxin B1

PONE-D-23-23404R1

Dear Dr. Xiaohua Zhu 

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Amel Mohamed El Asely

Academic Editor

PLOS ONE

Acceptance letter

Amel Mohamed El Asely

28 Nov 2023

PONE-D-23-23404R1

Transcriptome and metabolomics analysis of adaptive mechanism of Chinese mitten crab (Eriocheir sinensis) to aflatoxin B1

Dear Dr. Zhu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Amel Mohamed El Asely

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The OPLS-DA model validation in ML-C vs. ML-30m comparison.

    (TIF)

    S2 Fig. The OPLS-DA model validation in ML-C vs. ML-60m comparison.

    (TIF)

    S1 Table. Up-regulated DEGs in comparison between L-C vs. L-30m and L-C vs. L-60m.

    (XLSX)

    S2 Table. Down-regulated DEGs in comparison between L-C vs. L-30m and L-C vs. L-60m.

    (XLSX)

    S3 Table. Cored and up-regulated DEGs during AFB1 injection in hepatopancreas.

    (DOCX)

    S4 Table. DEGs in comparison between R-C vs. R-30m and R-C vs. R-60m.

    (XLSX)

    S5 Table. KEGG pathways were enriched by DAMs in ML-C vs. ML-30m comparison.

    (XLSX)

    S6 Table. KEGG pathways were enriched by DAMs in ML-C vs. ML-60m comparison.

    (XLSX)

    S7 Table. KEGG pathways were Co-enriched by DEGs and DAMs in C vs. 30 m comparison.

    (DOCX)

    S8 Table. KEGG pathways were Co-enriched by DEGs and DAMs in C vs. 60 m comparison.

    (DOCX)

    Attachment

    Submitted filename: Manuscript SSE3092023.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES